RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+4.78%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$599M
AUM Growth
+$599M
(+4.3%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
69.44%
Holding
34
New
7
Increased
17
Reduced
7
Closed
2
Top Buys
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$25.9M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$22.6M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$16.4M |
| 4 |
Edwards Lifesciences
EW
|
$13.9M |
| 5 |
PTC Therapeutics
PTCT
|
$10.6M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$33.6M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$20.6M |
| 3 |
BLUE
bluebird bio
BLUE
|
$14.3M |
| 4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$9.17M |
| 5 |
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
|
$4.2M |
Sector Composition
| 1 | Healthcare | 90.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
26
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.25M | 0.88% | 375,792 -656,578 | -64% | -$9.17M |
|
27
Apyx Medical
APYX
$75.3M
| $4.56M | 0.76% | 1,752,611 +613,011 | +54% | +$1.59M |
|
|
ZYNE
28
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $2.54M | 0.42% | 202,859 +2,859 | +1% | +$35.8K |
|
|
FPRX
29
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.2M | 0.37% | +100,377 | New | +$2.2M |
|
30
argenx
ARGX
$43.6B
| $1.6M | 0.27% | 25,260 +354 | +1% | +$22.4K |
|
|
RVNC
31
DELISTED
Revance Therapeutics, Inc.
RVNC
| $824K | 0.14% | +23,038 | New | +$824K |
|
|
SRTSW
32
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
| $98K | 0.02% | 151,400 -3,600 | -2% | -$2.33K |
|
|
BLUE
33
DELISTED
bluebird bio
BLUE
| – | – | -104,078 | Closed | -$14.3M |
|
|
FSTX
34
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| – | – | -249,095 | Closed | -$4.2M |
|